RSLS ReShape Lifesciences Inc. Total Debt to Capital

RSLS (reshapelifesciences.com) - company brandmark

ReShape Lifesciences (RSLS) relies on the expertise of a tight-knit circle of leading developers, which, combined with high physician confidence in the safety of Lap-Band systems, strengthens the brand's position. This chart of the company's price action demonstrates the 0.02 metric. The stability of the medical devices' value is ensured by offering a gentle alternative to traditional weight-loss surgeries.

ReShape Lifesciences Inc - RSLS Debt to Capital (period 07/04/2022 - 08/30/2025)

Comprehensive metric breakdowns and analytics for ReShape Lifesciences Inc. (RSLS)

- price and consensus price forecast:
Stock Quotes ReShape Lifesciences, Inc.|RSLS - Analyst Forecast Prices
- market capitalization data:
Market Capitalization ReShape Lifesciences|RSLS - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share ReShape Lifesciences|RSLS - Total Stockholders' Equity|Market Value to Book Value Ratio reshapelifesciences.com|RSLS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital ReShape Lifesciences|RSLS - Long-Term Debt to Capital|Short-Term Debt to Equity ReShape Lifesciences, Inc.|RSLS - Company Aggregate Indebtedness|Debts to Book Capitalization ReShape Lifesciences|RSLS - Long-Term Debt|Company Current Liabilities ReShape Lifesciences
Basic company analysis:ReShape Lifesciences RSLS
Finished products of ReShape Lifesciences, Inc.

This ratio determines the degree of business dependence on borrowed funds by comparing total liabilities to net asset value to assess financial stability and default risks. For ReShape Lifesciences (RSLS), this balance is critical when financing the development of smart sensors and Lap-Band systems, reflecting the shifting proportion of total debt to equity.

Analysis of competing companies

Dexcom (DXCM) - Total Debt to Equity Ratio|Aggregate Debt to Capital Penumbra Inc|Novanta Corp (NOVT) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio Haemonetics Company (HAE)|INSP: Total Debt to Capital|procept-biorobotics.com - Debt to Capital|Debt to Equity CONMED (CNMD)|PLSE - All Debt to Shareholders' Equity Ratio|INMD: Total Debt to Capital|PMI (Picard Group) - Total Debt to Capital|Debt to Equity Surmodics, Inc. SRDX|Aggregate Debt to Equity Senseonics Corp|NeuroPace - Total Debt to Capital|Debt to Capital tactilemedical.com TCMD|Total Debt to Equity Ratio SNWV (SANUWAVE Health, Inc.)|OM - Total Debt to Capital|Total Debt to Equity Ratio Electromed Inc ELMD|LNSR - Aggregate Debt to Capital|AVITA Medical - Total Debt to Capital|Profound Medical (PROF) - Total Debt to Capital Coefficient|Total Debt to Capital BDMD|Total Debt to Equity Ratio EDAP Medical (EDAP)|Apyx Medical (APYX) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio ICCM (icecure-medical.com)|Pulmonx - Debt to Equity|Total Debt to Equity Ratio TELA Bio Inc. TELA|CTSO (CytoSorbents Corp.) - Total Debt to Capital|SRTS - Debt to Capital|Total Debt to Capital Zynex, Inc.|electroCore (ECOR) - Debt to Equity Ratio|RBOT: Total Debt to Capital|Total Debt to Capital Coefficient Inspira Technologies Oxy B.H.N. Ltd|Total Debt to Capital ICU (SeaStar Medical Holding Corp)|Total Debt to Equity Ratio iridex.com (IRIX)|Total Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Beyond Air Inc - Total Debt to Capital|PFSA - Debt to Equity|STRATA Skin Sciences (SSKN) - Debt to Equity|Total Debt to Equity Ratio GlucoTrack GCTK|NanoVibronix Inc. (NAOV) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital VERO (Venus Concept Inc.)|Debt to Capital NUWE|AEMD: Debt to Equity|Debt to Capital Ratio asensus.com ASXC|Total Debt to Equity Ratio AVGR (Avinger, Inc)|Total Debt to Capital BioSig Technologies Inc. BSGM|Total Debt to Capital CUTR (Cutera, Inc.)|KNW: Total Debt to Capital Coefficient|Debt to Equity Inari Medical (NARI)|NVRO (Nevro Corp) - Aggregate Debt to Equity|Debt to Equity SILK